Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00547235
Expanded Access Status : No longer available (No accrual)
First Posted : October 22, 2007
Last Update Posted : August 24, 2010
National Cancer Institute (NCI)
Information provided by:
Fred Hutchinson Cancer Research Center

No Study Results Posted on for this Study
  Expanded Access Status : No longer available
  Estimated Primary Completion Date : December 2012
  Study Completion Date : No date given